Alexandra L. Degenhardt, MD will be the guest speaker at Keep S’myelin’s Tuesday, Sept. 20 meeting.

Her career in neurology has taken her from a residency in neurology at Beth Israel Deaconess Medical Center, to a Research Fellowship in Multiple Sclerosis at Radcliffe Infirmary-University of Oxford, UK. Just prior to joining the staff of Pen Bay Neurology, Dr. Degenhardt was the Director of NY Methodist Hospital’s MS clinic in Brooklyn, NY.

In addition to welcoming her to Maine, the group is looking forward to hearing updates on MS research and treatments and new MS therapies.

Multiple sclerosis is a chronic, often disabling disease that attacks the central nervous system. Symptoms may be mild, such as numbness in the limbs, or severe, such as paralysis or loss of vision. The progress, severity, and specific symptoms of MS are unpredictable and vary from one person to another. Though most people with MS learn to cope with the disease and continue to lead satisfying, productive lives, knowing about new advancements in treating this disease is a big part of coping effectively. The positive news is that ongoing research is making new discoveries constantly, and patients rely on the knowledge of experts like Degenhardt to bring those advancements to their attention.

Keep S’myelin, an awareness group for those with multiple sclerosis, their families, caregivers, and friends meets monthly at Kno-Wal-Lin Home Care and Hospice at 170 Pleasant St. in Rockland on the third Tuesday of the month at 3:30 p.m. Keep S’myelin is affiliated with the Greater New England Chapter of the National Multiple Sclerosis Society.

For more information, please call Tom at 354-0285 or Brian at 236-2307.